Financial incentives to carry autoinjectors
It is unclear whether providing people at risk of anaphylaxis with financial incentives increases how often they carry autoinjectors because the certainty of evidence is very low (supplement S8b). One trial in people aged 18 to 30 years found that financial incentives were associated with a 27% mean increase in the proportion of people carrying their autoinjector (statistically significant, CI not reported, very low certainty).11Cannuscio CC, Dupuis R, Graves A, Seymour JW, Kounaves S, Strupp E, Leri D, Frasso R, Grande D, Meisel ZF. A behavioral economics intervention to encourage epinephrine-carrying among food-allergic adults: a randomized controlled trial. Ann Allergy Asthma Immunol 2015;115(3):234-240.e1.